Protea Fund - Sectoral Biotech Opportunities Fund Class IF Fonds
8,63
EUR
+0,05
EUR
+0,58
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 8,85% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 8,85% |
| Amgen Inc | US0311621009 | 7,84% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,58% |
| AstraZeneca PLC ADR | US0463531089 | 4,53% |
| argenx SE ADR | US04016X1019 | 3,95% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,65% |
| Summit Therapeutics Inc Ordinary Shares | US86627T1088 | 2,83% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,59% |
| Insmed Inc | US4576693075 | 2,58% |
| Sonstige | 48,74% |